Context Therapeutics and Integral Molecular collaborate to develop novel anti-CLDN6 antibodies April 12, 2021
Treatment with Escozine results in apoptosis of various types of leukemia cancer cell lines April 12, 2021
Bristol Myers Squibb starts enrolling patients in phase I study of BMS-986158 in myelofibrosis April 9, 2021
Preliminary data from phase Ib trial of gedatolisib plus palbociclib and endocrine therapy April 9, 2021
RSS